These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21681743)

  • 1. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort.
    Grote VA; Rohrmann S; Dossus L; Nieters A; Halkjaer J; Tjønneland A; Overvad K; Stegger J; Chabbert-Buffet N; Boutron-Ruault MC; Clavel-Chapelon F; Teucher B; Becker S; Montonen J; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Tumino R; Vineis P; Mattiello A; Argüelles M; Duell EJ; Molina-Montes E; Larrañaga N; Chirlaque MD; Gurrea AB; Jeurnink SM; Peeters PH; Ye W; Sund M; Lindkvist B; Johansen D; Khaw KT; Wareham N; Crowe FL; Romieu I; Rinaldi S; Jenab M; Romaguera D; Michaud DS; Riboli E; Bas Bueno-de-Mesquita H; Kaaks R
    Int J Cancer; 2012 May; 130(10):2428-37. PubMed ID: 21681743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
    Bao Y; Giovannucci EL; Kraft P; Stampfer MJ; Ogino S; Ma J; Buring JE; Sesso HD; Lee IM; Gaziano JM; Rifai N; Pollak MN; Cochrane BB; Kaklamani V; Lin JH; Manson JE; Fuchs CS; Wolpin BM
    J Natl Cancer Inst; 2013 Jan; 105(2):95-103. PubMed ID: 23243202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?
    Nogueira LM; Newton CC; Pollak M; Silverman DT; Albanes D; Männistö S; Weinstein SJ; Jacobs EJ; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2017 Jun; 26(6):914-922. PubMed ID: 28096201
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.
    Stolzenberg-Solomon RZ; Weinstein S; Pollak M; Tao Y; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2008 Nov; 168(9):1047-55. PubMed ID: 18801887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort.
    Grote VA; Kaaks R; Nieters A; Tjønneland A; Halkjær J; Overvad K; Skjelbo Nielsen MR; Boutron-Ruault MC; Clavel-Chapelon F; Racine A; Teucher B; Becker S; Pischon T; Boeing H; Trichopoulou A; Cassapa C; Stratigakou V; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Rodríguez L; Duell EJ; Sánchez MJ; Dorronsoro M; Navarro C; Gurrea AB; Siersema PD; Peeters PH; Ye W; Sund M; Lindkvist B; Johansen D; Khaw KT; Wareham N; Allen NE; Travis RC; Fedirko V; Jenab M; Michaud DS; Chuang SC; Romaguera D; Bueno-de-Mesquita HB; Rohrmann S
    Br J Cancer; 2012 May; 106(11):1866-74. PubMed ID: 22617158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study.
    Aleksandrova K; Boeing H; Jenab M; Bueno-de-Mesquita HB; Jansen E; van Duijnhoven FJ; Fedirko V; Rinaldi S; Romieu I; Riboli E; Romaguera D; Westphal S; Overvad K; Tjønneland A; Boutron-Ruault MC; Clavel-Chapelon F; Kaaks R; Lukanova A; Trichopoulou A; Lagiou P; Trichopoulos D; Agnoli C; Mattiello A; Saieva C; Vineis P; Tumino R; Peeters PH; Argüelles M; Bonet C; Sánchez MJ; Dorronsoro M; Huerta JM; Barricarte A; Palmqvist R; Hallmans G; Khaw KT; Wareham N; Allen NE; Crowe FL; Pischon T
    Carcinogenesis; 2012 Jun; 33(6):1211-8. PubMed ID: 22431719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
    Wei EK; Giovannucci E; Fuchs CS; Willett WC; Mantzoros CS
    J Natl Cancer Inst; 2005 Nov; 97(22):1688-94. PubMed ID: 16288122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic cancer risk and nutrition-related methyl-group availability indicators in male smokers.
    Stolzenberg-Solomon RZ; Albanes D; Nieto FJ; Hartman TJ; Tangrea JA; Rautalahti M; Sehlub J; Virtamo J; Taylor PR
    J Natl Cancer Inst; 1999 Mar; 91(6):535-41. PubMed ID: 10088624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women.
    Heidemann C; Sun Q; van Dam RM; Meigs JB; Zhang C; Tworoger SS; Mantzoros CS; Hu FB
    Ann Intern Med; 2008 Sep; 149(5):307-16. PubMed ID: 18765700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort.
    Heidemann C; Hoffmann K; Spranger J; Klipstein-Grobusch K; Möhlig M; Pfeiffer AF; Boeing H;
    Diabetologia; 2005 Jun; 48(6):1126-34. PubMed ID: 15889235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of adiponectin and primary liver cancer risk in middle-aged Japanese adults with hepatitis virus infection: a nested case-control study.
    Michikawa T; Inoue M; Sawada N; Sasazuki S; Tanaka Y; Iwasaki M; Shimazu T; Yamaji T; Mizokami M; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2250-7. PubMed ID: 24045928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cotinine levels and pancreatic cancer in the EPIC cohort study.
    Leenders M; Chuang SC; Dahm CC; Overvad K; Ueland PM; Midttun O; Vollset SE; Tjønneland A; Halkjaer J; Jenab M; Clavel-Chapelon F; Boutron-Ruault MC; Kaaks R; Canzian F; Boeing H; Weikert C; Trichopoulou A; Bamia C; Naska A; Palli D; Pala V; Mattiello A; Tumino R; Sacerdote C; van Duijnhoven FJ; Peeters PH; van Gils CH; Lund E; Rodriguez L; Duell EJ; Pérez MJ; Molina-Montes E; Castaño JM; Barricarte A; Larrañaga N; Johansen D; Lindkvist B; Sund M; Ye W; Khaw KT; Wareham NJ; Michaud DS; Riboli E; Xun WW; Allen NE; Crowe FL; Bueno-de-Mesquita HB; Vineis P
    Int J Cancer; 2012 Aug; 131(4):997-1002. PubMed ID: 21953524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
    Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus.
    Krechler T; Zeman M; Vecka M; Macasek J; Jachymova M; Zima T; Zak A
    Neoplasma; 2011; 58(1):58-64. PubMed ID: 21067267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers.
    Stolzenberg-Solomon RZ; Graubard BI; Chari S; Limburg P; Taylor PR; Virtamo J; Albanes D
    JAMA; 2005 Dec; 294(22):2872-8. PubMed ID: 16352795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort.
    Katagiri R; Goto A; Nakagawa T; Nishiumi S; Kobayashi T; Hidaka A; Budhathoki S; Yamaji T; Sawada N; Shimazu T; Inoue M; Iwasaki M; Yoshida M; Tsugane S
    Gastroenterology; 2018 Nov; 155(5):1474-1482.e1. PubMed ID: 30076838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
    Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D
    Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women.
    Michaud DS; Wolpin B; Giovannucci E; Liu S; Cochrane B; Manson JE; Pollak MN; Ma J; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2101-9. PubMed ID: 17905943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.
    Inamura K; Song M; Jung S; Nishihara R; Yamauchi M; Lochhead P; Qian ZR; Kim SA; Mima K; Sukawa Y; Masuda A; Imamura Y; Zhang X; Pollak MN; Mantzoros CS; Harris CC; Giovannucci E; Fuchs CS; Cho E; Chan AT; Wu K; Ogino S
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
    J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.